NCT03742453 - Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis | Biotech Hunter

Enrollment

117

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

August 26, 2019

Study Completion Date

December 31, 2021

Conditions

Hepatocellular Carcinoma

Interventions

DIAGNOSTIC_TEST

contrast-enhanced ultrasound

CEUS is performed using SonoVue (Bracco, Milan, Italy) intravenous administration in eligible participants within a month before/after EOB-MRI.

DIAGNOSTIC_TEST

EOB-MRI

EOB-MRI is performed using standard dose of hepatocyte specific contrast media (primovist or eovist) according to standard protocol of our institution.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul